Caption Management’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Sell
219,100
-22,500
-9% -$105K 0.01% 1096
2026
Q1
$858K Sell
241,600
-835,000
-78% -$3.42M 0.01% 1069
2025
Q4
$5.08M Sell
1,076,600
-687,400
-39% -$3.06M 0.03% 514
2025
Q3
$8.45M Buy
+1,764,000
New +$6.95M 0.07% 327
2024
Q3
Sell
-350,000
Closed -$2.57M 1481
2024
Q2
$2.57M Sell
350,000
-300,000
-46% -$2.62M 0.04% 425
2024
Q1
$6.51M Sell
650,000
-2,000
-0.3% -$17.5K 0.1% 252
2023
Q4
$4.57M Sell
652,000
-248,000
-28% -$1.65M 0.06% 367
2023
Q3
$7.15M Buy
+900,000
New +$5.68M 0.11% 231
2021
Q3
Sell
-200,000
Closed -$8M 1687
2021
Q2
$8M Hold
200,000
0.1% 248
2021
Q1
$8.48M Buy
+200,000
New +$9.22M 0.18% 147

Other funds holding MSOS

Caption Management's MSOS Position: Q2 2026 in Review

Caption Management increased its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 47% in Q2 2026, buying an estimated $88.1K and bringing the position to 59,100 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #1410.

Caption Management first reported a position in MSOS in Q3 2023 and has held it in 7 quarters since. The position peaked at $3.51M in Q3 2023. 168 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • Caption Management held 59,100 shares of AdvisorShares Pure US Cannabis ETF worth $300K as of Q2 2026.
  • Caption Management bought 18,800 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $88.1K.
  • AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1410 holding.
  • Caption Management first reported a position in AdvisorShares Pure US Cannabis ETF in Q3 2023 and has held it in 7 quarters since.
  • Caption Management's AdvisorShares Pure US Cannabis ETF position peaked at $3.51M in Q3 2023.
  • 168 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.